Capstone Investment Advisors’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$245K Buy
+1,299
New +$274K ﹤0.01% 1446
2024
Q2
Sell
-5,496
Closed -$578K 2470
2024
Q1
$578K Buy
+5,496
New +$494K ﹤0.01% 1477
2017
Q1
Sell
-34,301
Closed -$509K 1117
2016
Q4
$509K Buy
+34,301
New +$615K 0.02% 581
2014
Q2
Sell
-100,000
Closed -$4.28M 459
2014
Q1
$4.28M Buy
100,000
+66,199
+196% +$2.92M 0.05% 180
2013
Q4
$1.42M Buy
+33,801
New +$1.47M 0.02% 376

Other funds holding THC

Capstone Investment Advisors's THC Position: Q1 2026 in Review

Capstone Investment Advisors opened a new position in Tenet Healthcare (THC) in Q1 2026: 1,299 shares worth $245K. The stake represents ﹤0.01% of the portfolio and ranks #1446 among its holdings. This is a return to the name: Capstone Investment Advisors previously reported a position in THC as recently as Q1 2024.

Capstone Investment Advisors first reported a position in THC in Q4 2013 and has held it in 5 quarters since. The position peaked at $4.28M in Q1 2014. 692 funds tracked by Wall St. Rank hold THC as of Q1 2026.

  • Capstone Investment Advisors held 1,299 shares of Tenet Healthcare worth $245K as of Q1 2026.
  • Tenet Healthcare was a new Capstone Investment Advisors position in Q1 2026.
  • Tenet Healthcare made up ﹤0.01% of Capstone Investment Advisors's portfolio in Q1 2026, its #1446 holding.
  • Capstone Investment Advisors first reported a position in Tenet Healthcare in Q4 2013 and has held it in 5 quarters since.
  • Capstone Investment Advisors's Tenet Healthcare position peaked at $4.28M in Q1 2014.
  • 692 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2026.

Based on Capstone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.